Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06975813
PHASE2

Magnesium Sulfate and Trigger Points

Sponsor: Fayoum University

View on ClinicalTrials.gov

Summary

The patients will be randomly assigned to one of the two groups according to the treatment method: group I (masseter group) and group II (masseter \&sternocleidomastoid group) where each patient will be injected 0.5ml in each trigger point (TrPs) of magnesium sulphate according to the treatment group by the same operator. The treatment method for TrPs will be the primary predictor variable. Patients will be examined at the following intervals: during diagnosis, 1-month, 3-months, and 6-months post-injection. The participated patients will be assessed using pain score measured on a 10-point visual analogue scale (VAS), the 0 indicating no pain and 10 indicating the worst pain ever

Official title: Efficacy of Isolated Masseter Versus Masseter- Sternocleidomastoid Trigger Points Injection by Magnesium Sulfate for Myofacial Pain

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-06-01

Completion Date

2026-01-27

Last Updated

2025-05-16

Healthy Volunteers

No

Interventions

DRUG

masseter muscle

masseter muscle trigger points injection by magnesium sulphate

DRUG

masseter and sternocleidomastoid muscle

masseter and sternocleidomastoid muscle trigger points injection by magnesium sulphate